Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum

State Legislatures Become Battlegrounds for Biosimilars

Maryland is the latest state to consider whether to include additional requirements for substitution of biological products.
Apr 11, 2013

Maryland is the latest state to consider whether to include additional requirements for substitution of biological products

Navigating the Global Manufacturing Supply Chain

As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.
Apr 10, 2013

As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.

Pfizer Voluntarily Recalls Levoxyl

Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.
Apr 8, 2013

Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.

Eli Lilly Considers Investment in US Insulin-Manufacturing Capacity

Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.
Apr 8, 2013

Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.

GlaxoSmithKline Tops Industry Rankings for Access to Medicines

The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.
Apr 3, 2013

The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.

The Plan by AstraZeneca CEO Pascal Soriot to Revitalize the Company

Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.
Apr 3, 2013

Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.

Indian Supreme Court Rejects Patent for Glivec by Novartis

Ruling has implications for intellectual property protection for innovator drugs in India.
Apr 3, 2013

Ruling has implications for intellectual property protection for innovator drugs in India.

Fine-Chemical Producers Make Targeted Investments

Contract API manufacturers proceed with select investment in capacity and service additions.
Apr 2, 2013

Contract API manufacturers proceed with select investment in capacity and service additions.

Novartis Suffers Setback in Indian Patent Case for Glivec

Apr 2, 2013

Novartis loses an appeal in seeking patent protection in India for its anticancer drug.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here